Associations of Lp(a) with CV morbidity and mortality - PACE-CME

Associations of Lpa with CV morbidity and mortality

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Lp(a) and immune metabolism
Lp(a) and immune metabolism
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) and immune metabolism
- Jeffrey Kroon, PhD
Lp(a) apheresis and CVD risk modulation
Lp(a) apheresis and CVD risk modulation
The Imminent danger of Lp(a): Time to face to challenge
Lp(a) apheresis and CVD risk modulation
- Elisa Waldmann, MD
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
The Imminent danger of Lp(a): Time to face to challenge
Phase II data on Lp(a) lowering, followed by NHLBI recommendation
- Prof. Sam Tsimikas
LDL vs Lp(a) cholesterol: confounding
LDL vs Lp(a) cholesterol: confounding
The Imminent danger of Lp(a): Time to face to challenge
LDL vs Lp(a) cholesterol: confounding
- Calvin Yeang, MD, PhD